SwiftPharma

Karel Van De Woestijnestraat 6

9000 Gent

BE

SwiftPharma

Foundation date

04/02/2022

Sector

#Biotechnology - other

Subsector

Development of recombinant biologics using plants as mini-bioreactors. Our technology combines speed, agility, scalability, safety, and low-cost production completely animal-free

Upcoming events

News by SwiftPharma

  • SwiftPharma and AntoXa to present plant-made anti-ricin antibody technology to NATO expert panel

    Thursday August 15th 2024

  • Biotech company SwiftPharma receives capital injection to achieve ambitious growth

    Thursday June 27th 2024

  • SwiftPharma to Join Groundbreaking €41 Million PharmECO Project.

    Wednesday June 26th 2024

Jobs by SwiftPharma